Narrative Update on China Pacific Insurance (Group)
Analysts have raised their price target for China Pacific Insurance (Group) from ¥42.41 to ¥43.10, citing higher projected revenue growth, even though there is some moderation in profit margin expectations.
What's in the News
- Board meeting on October 30, 2025 will review and approve third quarter results and related disclosures (Key Developments)
- Shareholders at the August 29, 2025 EGM approved amendments to the Articles of Association (Key Developments)
- Special Shareholders Meeting on August 29, 2025 addressed the proposed dissolution of the Board of Supervisors and multiple amendments to key company procedures (Key Developments)
- Board meeting on August 28, 2025 considered and approved the interim results for the first half of 2025 and related disclosures (Key Developments)
Valuation Changes
- The consensus analyst price target has risen slightly from CN¥42.41 to CN¥43.10.
- The discount rate has decreased modestly from 7.29% to 7.19%.
- The revenue growth projection increased significantly from 8.42% to 13.20%.
- The net profit margin expectation has declined from 14.03% to 12.43%.
- The future P/E ratio is now forecast at 8.43x, down from 8.83x.
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.